Autoimmune glomerulonephritis in a multiple sclerosis patient after cladribine treatment

Background:Oral cladribine is an approved disease-modifying drug for the treatment of relapsing multiple sclerosis. In controlled clinical trials as well as in post marketing safety assessments, au...